Evaluation of fetuin-A and carotid intima-media thickness in adolescent type 1 diabetic patients

Journal of Pediatric Endocrinology and Metabolism

Volumn 28, Issue 3-4, 2015, Pages 287-292

  Abd El Dayem, Soha M ^a   Battah, Ahmed A ^b   El Bohy, Abo El Magd ^b   El Shehaby, Amal ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

carotid intima media thickness; fetuin A; type 1 diabetes

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; FETUIN A; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; HIP CIRCUMFERENCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROTEIN BLOTTING; URINALYSIS; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; ADULT; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; METABOLISM; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA-2-HS-GLYCOPROTEIN; BLOOD PRESSURE; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; YOUNG ADULT;

EID: 84924916873     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2014-0290     Document Type: Article

References (29)

1. Pedersen KO. Fetuin, a new globulin isolated from serum. Nature 1944;154:575-6.
2. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66.
3. Merx MW, Schäfer C, Westenfeld R, Brandenburg V, Hidajat S, et al. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol 2005;16:3357-64.
4. Emoto M, Mori K, Lee E, Kawano N, Yamazaki Y, et al. Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metabol Clin Exp 2010;59:873-8.
5. Mori K, Emoto M, Araki T, Yokoyama H, Lee E, et al. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism 2008;57:1248-52.
6. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-7.
7. Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and non diabetic subjects. Diabetes Care 2006;29:468.
8. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, et al. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006;113:1760-7.
9. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, et al. Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008;118:2555-62.
10. Rittig K, Thamer C, Haupt A, Machann J, Peter A, et al. High plasma fetuin-A is associated with increased carotid intimamedia thickness in a middle-aged population. Atherosclerosis 2009;207:341-2.
11. Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 1989;58:631-40.
12. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 2008;12:3:e1765. doi: 10.1371/journal. pone.0001765.
13. Fiore CE, Celotta G, Politi GG, Di Pino L, Castelli Z, et al. Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. Atherosclerosis 2007;195:110-5.
14. Mori K, Emoto M, Araki T, Yokoyama H, Teramura M, et al. Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 2007;66:246-50.
15. Tanner JM, Hiernaux J, Jarman S. Growth and physical studies. In: Weiner JS, Lourie JA, editors. Human biology: a guide to field methods. Oxford: Blackwell Scientific Publishers, 1969:3-41.
16. Cameron N. The methods of auxological anthropology. In: Falkner F, Tanner JM, editors. Human growth 3 methodology. New York: Plenum Press, 1986:3-46.
17. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67.
18. Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, et al. Endothelial dysfunction and increased arterial intimamedia thickness in children with type 1 diabetes. Circulation 2004;109:1750-5. [Abstract/Free Full Text].
19. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 2003;41:661-5.
20. Brix JM, Stingl H, Hollerl F, Schernthaner GH, Kopp HP, et al. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab 2010;95:4877-81.
21. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:4479-85.
22. Ramadan A, Shoukry A, Ismail MI, Borai M. Serum fetuin-A levels in type 2 diabetes patients with early diabetic nephropathy: it's relation to diabetes control. J Am Sci 2011;7:759-65.
23. Kilian Rittig A, Thamera C, Haupta A, Machann J, Peter A, et al. High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. Atherosclerosis 2009;207:341-2.
24. Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006;29:468.
25. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 2005;67:1070-7.
26. Roos M, Lutz J, Salmhofer H, Luppa P, Knauss A, et al. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) 2008;68:660-5.
27. Lehtinen AB, Burdon KP, Lewis JP, Langefeld CD, Ziegler JT, et al. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab 2007;92:345-52.
28. Stein EA. Statins and children: whom do we treat and when? Circulation 2007;116:594-5.
29. Haller MJ, Stein JM, Shuster JJ, Theriaque D, Samyn MM, et al. Atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2009;22:65-8.